Medical and Endoscopic Therapies for Angiodysplasia and Gastric Antral Vascular Ectasia: A Systematic Review

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 4, 2014, Pages 571-582

  Swanson, Eric ^a   Mahgoub, Amar ^a   MacDonald, Roderick ^b   Shaukat, Aasma ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Minnesota Evidence based Practice Center   (United States)

Author keywords

Angiodysplasia; Comparison analysis; Gastric antral vascular ectasia; Systematic review

Indexed keywords

ESTROGEN; HEMOGLOBIN; OCTREOTIDE; PROGESTERONE; THALIDOMIDE;

ANGIODYSPLASIA; ARGON PLASMA COAGULATION; BLEEDING; COMPLICATION; CONSERVATIVE TREATMENT; CRYOTHERAPY; ENDOSCOPIC THERAPY; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFORMATION RETRIEVAL; IRON THERAPY; MORTALITY; NEODYMIUM YAG LASER; PERFORATION; RENDU OSLER WEBER DISEASE; REVIEW; SCLEROTHERAPY; STOMACH ANTRUM VASCULAR ECTASIA; SYSTEMATIC REVIEW; TRANSFUSION; TREATMENT FAILURE; VON WILLEBRAND DISEASE;

ANGIODYSPLASIA; COMPARISON ANALYSIS; GASTRIC ANTRAL VASCULAR ECTASIA; SYSTEMATIC REVIEW;

ANGIODYSPLASIA; ENDOSCOPY; GASTRIC ANTRAL VASCULAR ECTASIA; GASTROINTESTINAL AGENTS; HUMANS; RECURRENCE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84896095718     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.08.038     Document Type: Review

References (86)

1. Kjeldsen A.D., Kjeldsen J. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 2000, 95:415-418.
2. Foutch P.G., Rex D.K., Lieberman D.A. Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people. Am J Gastroenterol 1995, 90:564-567.
3. Diggs N.G., Holub J.L., Lieberman D.A., et al. Factors that contribute to blood loss in patients with colonic angiodysplasia from a population-based study. Clin Gastroenterol Hepatol 2011, 9:415-420. quiz e49.
4. Fleischer D. Etiology and prevalence of severe persistent upper gastrointestinal bleeding. Gastroenterology 1983, 84:538-543.
5. Tedesco F.J., Waye J.D., Raskin J.B., et al. Colonoscopic evaluation of rectal bleeding: a study of 304 patients. Ann Intern Med 1978, 89:907-909.
6. Lewis B.S., Waye J.D. Chronic gastrointestinal bleeding of obscure origin: role of small bowel enteroscopy. Gastroenterology 1988, 94:1117-1120.
7. Lewis B.S., Kornbluth A., Waye J.D. Small bowel tumours: yield of enteroscopy. Gut 1991, 32:763-765.
8. Schmit A., Gay F., Adler M., et al. Diagnostic efficacy of push-enteroscopy and long-term follow-up of patients with small bowel angiodysplasias. Dig Dis Sci 1996, 41:2348-2352.
9. Ell C., Remke S., May A., et al. The first prospective controlled trial comparing wireless capsule endoscopy with push enteroscopy in chronic gastrointestinal bleeding. Endoscopy 2002, 34:685-689.
10. Yamada M. Gastroduodenal vascular ectasia in patients with liver cirrhosis. Dig Endosc 1999, 11:241-245.
11. Dulai G.S., Jensen D.M., Kovacs T.O., et al. Endoscopic treatment outcomes in watermelon stomach patients with and without portal hypertension. Endoscopy 2004, 36:68-72.
12. Smith G.F., Ellyson J.H., Parks S.N., et al. Angiodysplasia of the colon: a review of 17 cases. Arch Surg 1984, 119:532-536.
13. Gupta N., Longo W.E., Vernava A.M. Angiodysplasia of the lower gastrointestinal tract: an entity readily diagnosed by colonoscopy and primarily managed nonoperatively. Dis Colon Rectum 1995, 38:979-982.
14. Spahr L., Villeneuve J.P., Dufresne M.P., et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 1999, 44:739-742.
15. Borsch G. Diffuse gastric antral vascular ectasia: the "watermelon stomach" revisited. Am J Gastroenterol 1987, 82:1333-1334.
16. Kamath P.S., Lacerda M., Ahlquist D.A., et al. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000, 118:905-911.
17. Kanwal F., White D. Systematic reviews and meta-analyses in Clinical Gastroenterology and Hepatology. Clin Gastroenterol Hepatol 2012, 10:1184-1186.
18. Schulz K.F., Grimes D.A. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002, 359:614-618.
19. Atkins D., Best D., Briss P.A., et al. Grading quality of evidence and strength of recommendations. BMJ 2004, 328:1490.
20. Junquera F., Feu F., Papo M., et al. Amulticenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia. Gastroenterology 2001, 121:1073-1079.
21. Lewis B.S., Salomon P., Rivera-MacMurray S., et al. Does hormonal therapy have any benefit for bleeding angiodysplasia?. JClin Gastroenterol 1992, 15:99-103.
22. Junquera F., Saperas E., Videla S., et al. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia. Am J Gastroenterol 2007, 102:254-260.
23. Ge Z.Z., Chen H.M., Gao Y.J., et al. Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation. Gastroenterology 2011, 141:1629-1637.
24. Barkin J.S., Ross B.S. Medical therapy for chronic gastrointestinal bleeding of obscure origin. Am J Gastroenterol 1998, 93:1250-1254.
25. Bronner M.H., Pate M.B., Cunningham J.T., et al. Estrogen-progesterone therapy for bleeding gastrointestinal telangiectasias in chronic renal failure: an uncontrolled trial. Ann Intern Med 1986, 105:371-374.
26. Bon C., Aparicio T., Vincent M., et al. Long-acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia. Aliment Pharmacol Ther 2012, 36:587-593.
27. Nardone G., Rocco A., Balzano T., et al. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 1999, 13:1429-1436.
28. Scaglione G., Pietrini L., Russo F., et al. Long-acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia. Aliment Pharmacol Ther 2007, 26:935-942.
29. Garrido A., Sayago M., Lopez J., et al. Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias. Rev Esp Enferm Dig 2012, 104:69-71.
30. Saperas E., Videla S., Dot J., et al. Risk factors for recurrence of acute gastrointestinal bleeding from angiodysplasia. Eur J Gastroenterol Hepatol 2009, 21:1333-1339.
31. Askin M.P., Lewis B.S. Push enteroscopic cauterization: long-term follow-up of 83 patients with bleeding small intestinal angiodysplasia. Gastrointest Endosc 1996, 43:580-583.
32. Richter J.M., Christensen M.R., Colditz G.A., et al. Angiodysplasia: natural history and efficacy of therapeutic interventions. Dig Dis Sci 1989, 34:1542-1546.
33. Trudel J.L., Fazio V.W., Sivak M.V. Colonoscopic diagnosis and treatment of arteriovenous malformations in chronic lower gastrointestinal bleeding: clinical accuracy and efficacy. Dis Colon Rectum 1988, 31:107-110.
34. Junquera F., Brullet E., Campo R., et al. Usefulness of endoscopic band ligation for bleeding small bowel vascular lesions. Gastrointest Endosc 2003, 58:274-279.
35. Ljubicic N. Endoscopic detachable mini-loop ligation for treatment of gastroduodenal angiodysplasia: case study of 11 patients with long-term follow-up. Gastrointest Endosc 2004, 59:420-423.
36. Cello J.P., Grendell J.H. Endoscopic laser treatment for gastrointestinal vascular ectasias. Ann Intern Med 1986, 104:352-354.
37. Eickhoff A., Enderle M.D., Hartmann D., et al. Effectiveness and safety of PRECISE APC for the treatment of bleeding gastrointestinal angiodysplasia: a retrospective evaluation. ZGastroenterol 2011, 49:195-200.
38. Chiu Y.C., Lu L.S., Wu K.L., et al. Comparison of argon plasma coagulation in management of upper gastrointestinal angiodysplasia and gastric antral vascular ectasia hemorrhage. BMC Gastroenterol 2012, 12:67.
39. Kwan V., Bourke M.J., Williams S.J., et al. Argon plasma coagulation in the management of symptomatic gastrointestinal vascular lesions: experience in 100 consecutive patients with long-term follow-up. Am J Gastroenterol 2006, 101:58-63.
40. May A., Friesing-Sosnik T., Manner H., et al. Long-term outcome after argon plasma coagulation of small-bowel lesions using double-balloon enteroscopy in patients with mid-gastrointestinal bleeding. Endoscopy 2011, 43:759-765.
41. Olmos J.A., Marcolongo M., Pogorelsky V., et al. Long-term outcome of argon plasma ablation therapy for bleeding in 100 consecutive patients with colonic angiodysplasia. Dis Colon Rectum 2006, 49:1507-1516.
42. Olmos J.A., Marcolongo M., Pogorelsky V., et al. Argon plasma coagulation for prevention of recurrent bleeding from GI angiodysplasias. Gastrointest Endosc 2004, 60:881-886.
43. Bown S.G., Swain C.P., Storey D.W., et al. Endoscopic laser treatment of vascular anomalies of the upper gastrointestinal tract. Gut 1985, 26:1338-1348.
44. Gostout C.J., Bowyer B.A., Ahlquist D.A., et al. Mucosal vascular malformations of the gastrointestinal tract: clinical observations and results of endoscopic neodymium: yttrium-aluminum-garnet laser therapy. Mayo Clin Proc 1988, 63:993-1003.
45. Mathus-Vliegen E.M. Laser treatment of intestinal vascular abnormalities. Int J Colorectal Dis 1989, 4:20-25.
46. Naveau S., Aubert A., Poynard T., et al. Long-term results of treatment of vascular malformations of the gastrointestinal tract by neodymium YAG laser photocoagulation. Dig Dis Sci 1990, 35:821-826.
47. Rutgeerts P., Van Gompel F., Geboes K., et al. Long term results of treatment of vascular malformations of the gastrointestinal tract by neodymium Yag laser photocoagulation. Gut 1985, 26:586-593.
48. Sargeant I.R., Loizou L.A., Rampton D., et al. Laser ablation of upper gastrointestinal vascular ectasias: long term results. Gut 1993, 34:470-475.
49. Hayat M., Axon A.T., O'Mahony S. Diagnostic yield and effect on clinical outcomes of push enteroscopy in suspected small-bowel bleeding. Endoscopy 2000, 32:369-372.
50. Shackel N.A., Bowen D.G., Selby W.S. Video push enteroscopy in the investigation of small bowel disease: defining clinical indications and outcomes. Aust N Z J Med 1998, 28:198-203.
51. Howard O.M., Buchanan J.D., Hunt R.H. Angiodysplasia of the colon: experience of 26 cases. Lancet 1982, 2:16-19.
52. Rogers B.H. Endoscopic diagnosis and therapy of mucosal vascular abnormalities of the gastrointestinal tract occurring in elderly patients and associated with cardiac, vascular, and pulmonary disease. Gastrointest Endosc 1980, 26:134-138.
53. Foutch P.G., Sawyer R., Sanowski R.A. Push-enteroscopy for diagnosis of patients with gastrointestinal bleeding of obscure origin. Gastrointest Endosc 1990, 36:337-341.
54. Bemvenuti G.A., Julich M.M. Ethanolamine injection for sclerotherapy of angiodysplasia of the colon. Endoscopy 1998, 30:564-569.
55. Tran A., Villeneuve J.P., Bilodeau M., et al. Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. Am J Gastroenterol 1999, 94:2909-2911.
56. Sato T., Yamazaki K., Akaike J. Endoscopic band ligation versus argon plasma coagulation for gastric antral vascular ectasia associated with liver diseases. Dig Endosc 2012, 24:237-242.
57. Wells C.D., Harrison M.E., Gurudu S.R., et al. Treatment of gastric antral vascular ectasia (watermelon stomach) with endoscopic band ligation. Gastrointest Endosc 2008, 68:231-236.
58. Bhatti M.A., Khan A.A., Alam A., et al. Efficacy of argon plasma coagulation in gastric vascular ectasia in patients with liver cirrhosis. JColl Physicians Surg Pak 2009, 19:219-222.
59. Chaves D.M., Sakai P., Oliveira C.V., et al. Watermelon stomach: clinical aspects and treatment with argon plasma coagulation. Arq Gastroenterol 2006, 43:191-195.
60. Fuccio L., Zagari R.M., Serrani M., et al. Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia-related bleeding in patients with liver cirrhosis. Digestion 2009, 79:143-150.
61. Herrera S., Bordas J.M., Llach J., et al. The beneficial effects of argon plasma coagulation in the management of different types of gastric vascular ectasia lesions in patients admitted for GI hemorrhage. Gastrointest Endosc 2008, 68:440-446.
62. Lecleire S., Ben-Soussan E., Antonietti M., et al. Bleeding gastric vascular ectasia treated by argon plasma coagulation: a comparison between patients with and without cirrhosis. Gastrointest Endosc 2008, 67:219-225.
63. Naga M., Esmat S., Naguib M., et al. Long-term effect of argon plasma coagulation (APC) in the treatment of gastric antral vascular ectasia (GAVE). Arab J Gastroenterol 2011, 12:40-43.
64. Probst A., Scheubel R., Wienbeck M. Treatment of watermelon stomach (GAVE syndrome) by means of endoscopic argon plasma coagulation (APC): long-term outcome. ZGastroenterol 2001, 39:447-452.
65. Roman S., Saurin J.C., Dumortier J., et al. Tolerance and efficacy of argon plasma coagulation for controlling bleeding in patients with typical and atypical manifestations of watermelon stomach. Endoscopy 2003, 35:1024-1028.
66. Sebastian S., McLoughlin R., Qasim A., et al. Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia (watermelon stomach): long-term results. Dig Liver Dis 2004, 36:212-217.
67. Yusoff I., Brennan F., Ormonde D., et al. Argon plasma coagulation for treatment of watermelon stomach. Endoscopy 2002, 34:407-410.
68. Bourke M.J., Hope R.L., Boyd P., et al. Endoscopic laser therapy for watermelon stomach. JGastroenterol Hepatol 1996, 11:832-834.
69. Calamia K.T., Scolapio J.S., Viggiano T.R. Endoscopic YAG laser treatment of watermelon stomach (gastric antral vascular ectasia) in patients with systemic sclerosis. Clin Exp Rheumatol 2000, 18:605-608.
70. Geller A., Gostout C.J., Balm R.K. Development of hyperplastic polyps following laser therapy for watermelon stomach. Gastrointest Endosc 1996, 43:54-56.
71. Gostout C.J., Viggiano T.R., Ahlquist D.A., et al. The clinical and endoscopic spectrum of the watermelon stomach. JClin Gastroenterol 1992, 15:256-263.
72. Liberski S.M., McGarrity T.J., Hartle R.J., et al. The watermelon stomach: long-term outcome in patients treated with Nd:YAG laser therapy. Gastrointest Endosc 1994, 40:584-587.
73. Mathou N.G., Lovat L.B., Thorpe S.M., et al. Nd:YAG laser induces long-term remission in transfusion-dependent patients with watermelon stomach. Lasers Med Sci 2004, 18:213-218.
74. Potamiano S., Carter C.R., Anderson J.R. Endoscopic laser treatment of diffuse gastric antral vascular ectasia. Gut 1994, 35:461-463.
75. Selinger R.R., McDonald G.B., Hockenbery D.M., et al. Efficacy of neodymium:YAG laser therapy for gastric antral vascular ectasia (GAVE) following hematopoietic cell transplant. Bone Marrow Transplant 2006, 37:191-197.
76. Petrini J.L., Johnston J.H. Heat probe treatment for antral vascular ectasia. Gastrointest Endosc 1989, 35:324-328.
77. Kantsevoy S.V., Cruz-Correa M.R., Vaughn C.A., et al. Endoscopic cryotherapy for the treatment of bleeding mucosal vascular lesions of the GI tract: a pilot study. Gastrointest Endosc 2003, 57:403-406.
78. Cho S., Zanati S., Yong E., et al. Endoscopic cryotherapy for the management of gastric antral vascular ectasia. Gastrointest Endosc 2008, 68:895-902.
79. Van Cutsem E. Long-term effect of hormonal therapy for bleeding gastrointestinal vascular malformations. Eur J Gastroenterol Hepatol 1993, 5:439-443.
80. Van Cutsem E., Rutgeerts P., Vantrappen G. Treatment of bleeding gastrointestinal vascular malformations with oestrogen-progesterone. Lancet 1990, 335:953-955.
81. Bauditz J., Lochs H., Voderholzer W. Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide. Endoscopy 2006, 38:1036-1039.
82. Kamalaporn P., Saravanan R., Cirocco M., et al. Thalidomide for the treatment of chronic gastrointestinal bleeding from angiodysplasias: a case series. Eur J Gastroenterol Hepatol 2009, 21:1347-1350.
83. Barrie R., Woltering E.A., Hajarizadeh H., et al. Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent. JSurg Res 1993, 55:446-450.
84. D'Amato R.J., Loughnan M.S., Flynn E., et al. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A 1994, 91:4082-4085.
85. Ripoll C., Garcia-Tsao G. Management of gastropathy and gastric vascular ectasia in portal hypertension. Clin Liver Dis 2010, 14:281-295.
86. Ripoll C., Garcia-Tsao G. The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis 2011, 43:345-351.